| Pharmaceutical active ingredients: |
| Flunixin Meglumine |
| Available forms, composition and doses of Supressor: |
| Injectable; Injection; Flunixin Meglumine 5% |
| Supressor medical category: |
| Veterinary; Pet Meds:Horses |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| ATCICD-10 |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Norbrook Laboratories |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Supres | Cetirizine | Helios Pharmaceuticals |
| Supres | Chlorothiazide; Methyldopa | Merck |
| Supres | Hydralazine Hydrochloride | Sanofi-Aventis |
| Supresol | Methylprednisolone Sodium Succinate | Biologici Italia Laboratories |
| Supressin | Doxazosin Mesylate | Pfizer |
| Supresta | Mycophenolic Acid (Mycophenolate Mofetil) | Veropharm |
| Suprex | Isoxsuprine | Intra Labs India |
| Suprex | Sulfamethoxazole; Trimethoprim | Terramedic; Metro Drug Distribution |
| Suprex Forte | Sulfamethoxazole; Trimethoprim | Terramedic; Metro Drug Distribution |
| Suprexon | Epinephrine; Guanethidine Monosulfate | Novartis; Ciba Vision |